Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.

Core-shell structures made of hydrogel could enable more efficient uptake in the body.

Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.

The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.

SMART researchers find the enzyne RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.

Ultrasound research specialist and 2023 MIT Excellence Award winner Nicole Henning adapts ultrasound technology for more sensitive, less invasive imaging for disease modeling.

MIT researchers develop "FrameDiff," a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.

SMART researchers combine rifaximin and clarithromycin to effectively restore the latter drug's efficacy.

Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.

Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.